Skip to main content
Drug bottle and Pill

Compare Epivir vs. Descovy

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Lamivudine (Epivir) and Descovy (emtricitabine/tenofovir alafenamide) are both antiretroviral medications used to treat HIV. However, they belong to different medication classes and have distinct uses and characteristics. Lamivudine (Epivir) is a nucleoside reverse transcriptase inhibitor (NRTI) used for treating both HIV and chronic hepatitis B virus (HBV) infections, though it is not interchangeable between its brands for these conditions. Descovy, a combination of emtricitabine and tenofovir alafenamide, is also an NRTI but is used with other HIV medications for HIV treatment or by itself as pre-exposure prophylaxis (PrEP) to prevent HIV, except for receptive vaginal sex. Lamivudine is available in both tablet and oral solution forms, while Descovy is available as a tablet. Common side effects of lamivudine include headache, nausea, and fatigue, whereas Descovy may cause nausea and diarrhea. Both medications require regular blood tests to monitor for side effects, but Descovy has specific interactions with other medications that can affect its effectiveness. Additionally, while lamivudine is available in generic form, Descovy is not.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.